NCT05291728 Screening for Early Gastric Cancer in Shaanxi Province
| NCT ID | NCT05291728 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Second Affiliated Hospital of Xi'an Jiaotong University |
| Condition | Early Gastric Cancer |
| Study Type | OBSERVATIONAL |
| Enrollment | 12,500,000 participants |
| Start Date | 2020-10-01 |
| Primary Completion | 2026-10-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 12,500,000 participants in total. It began in 2020-10-01 with a primary completion date of 2026-10-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study collect the relevant data of local residents over 20 years old in 11 regions of Shaanxi Province, The basic information of the subjects was collected by filling in the questionnaire, and serum helicobacter pylori antibody detection was completed at the same time. The expert group determined the high-risk population of gastric cancer after comprehensive evaluation. All the high-risk population of gastric cancer without contraindications underwent electronic gastroscopy in the designated hospital after signing the informed consent. By collecting and analyzing data, early gastric cancer screening was completed and a new gastric cancer risk assessment model was established to evaluate the prevalence of dyspepsia, gastroesophageal reflux disease and precancerous lesions in the natural population of Shaanxi Province, as well as helicobacter pylori infection, radical treatment and recurrence rate.
Eligibility Criteria
Inclusion Criteria: * Local resident over 20 years old. * Obtain verbal informed consent of the subject. Exclusion Criteria: * Refused to participate in this research project. * Questionnaires or serological tests for helicobacter pylori antibodies were not completed. * This study was not completed due to other reasons.
Contact & Investigator
jinhai Wang, MD
STUDY DIRECTOR
Second Affilated Hospital of Xi'an Jiaotong University
Frequently Asked Questions
Who can join the NCT05291728 clinical trial?
This trial is open to participants of all sexes, aged 20 Years or older, studying Early Gastric Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05291728 currently recruiting?
Yes, NCT05291728 is actively recruiting participants. Contact the research team at jinhaiwang@hotmail.com for enrollment information.
Where is the NCT05291728 trial being conducted?
This trial is being conducted at Xi'an, China.
Who is sponsoring the NCT05291728 clinical trial?
NCT05291728 is sponsored by Second Affiliated Hospital of Xi'an Jiaotong University. The principal investigator is jinhai Wang, MD at Second Affilated Hospital of Xi'an Jiaotong University. The trial plans to enroll 12,500,000 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.